TREM2 and Alzheimer disease: In addition, a growing number of genome-wide association studies have demonstrated that many AD risk genes, such as TREM2, are highly expressed on microglia, indicating that these molecules can be promising targets for antibodies to modulate microglial function and the neuro-immune system in the brain [93].